Carcinomatosis — Trials

Carcinomatosis — Trials · CancerIndex

Clinical trials

Registered studies

221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 74
Recruiting: 42
Ph III recruiting: 2
Growth YoY: —
Industry share: 4%
Top sponsor: Guangzhou Medical University
Termination share: 26%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (24)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07001748	Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity(STOPGAP II)	recruiting	Phase 2 / Phase 3	148	ECOG-ACRIN Cancer Research GroupNETWORK	1	Aug 19, 2026	clinicaltrials
NCT06513065	Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)(HIPEC-PMP)	recruiting	Phase 3	176	University of SouthamptonOTHER